Both mTORC1-S6K1 and AMPK pathways have been implicated in insulin resistance and lipogenesis in the liver in obesity at least in part through regulation of SREBP-1c gene expression and activation4, 5, 6, 7, 43. The gene discussed is SREBF1; the disease is Insulin resistance.